StonvexLoading…
StonvexStonvexStonvexCore line items from TLRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $821.31M | $788.94M | $627.12M | $628.37M |
Operating Income | $-2.28B | $-174.75M | $-1.37B | $-610.40M |
Net Income | $-2.19B | $-244.98M | $-1.45B | $-476.80M |
EPS (Diluted) | $-2.46 | $-0.33 | $-2.35 | $-0.99 |
Total Assets | $2.07B | $4.22B | $4.31B | $5.45B |
Total Liabilities | $584.75M | $778.49M | $977.32M | $1.01B |
Cash & Equivalents | $221.67M | $228.34M | $206.63M | $415.91M |
Free Cash Flow OCF − CapEx | $-127.52M | $-60.15M | $-12.89M | $-211.33M |
Shares Outstanding | 1.06B | 831.93M | 656.66M | 532.67M |